TRPM7 and neurodegenerative disease: Finally, the recent finding that CBDA and CBGA act as inhibitors of TRPM7 (Suzuki et al. 2023), a receptor channel highly expressed in neuronal cells and supposed to play a relevant role in neurodegenerative diseases (Sun et al. 2015), prompted us to evaluate whether its expression level is affected by the treatment of βA peptide.